{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:10:05Z","timestamp":1789103405779,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010226","name":"Department of Education of Guangdong Province","doi-asserted-by":"publisher","award":["2016KCXTD005"],"award-info":[{"award-number":["2016KCXTD005"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010226","name":"Department of Education of Guangdong Province","doi-asserted-by":"publisher","award":["2017KSYS010"],"award-info":[{"award-number":["2017KSYS010"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010226","name":"Department of Education of Guangdong Province","doi-asserted-by":"publisher","award":["2017KZDXM084"],"award-info":[{"award-number":["2017KZDXM084"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010226","name":"Department of Education of Guangdong Province","doi-asserted-by":"publisher","award":["2019KZDZX2003"],"award-info":[{"award-number":["2019KZDZX2003"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011492","name":"Bureau of Science and Technology of Jiangmen Municipality","doi-asserted-by":"publisher","award":["2016350100170008351"],"award-info":[{"award-number":["2016350100170008351"]}],"id":[{"id":"10.13039\/501100011492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011492","name":"Bureau of Science and Technology of Jiangmen Municipality","doi-asserted-by":"publisher","award":["2018110100330005446"],"award-info":[{"award-number":["2018110100330005446"]}],"id":[{"id":"10.13039\/501100011492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011132","name":"Rutgers, The State University of New Jersey","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejphar.2020.173840","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T18:03:42Z","timestamp":1608833022000},"page":"173840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cancer sphere-forming cells"],"prefix":"10.1016","volume":"893","author":[{"given":"Xue-Tao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ran","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Yan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Den-Gao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Goodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2020.173840_bib1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2015.01.001","article-title":"Cancer stem cells: the promise and the potential","volume":"42","author":"Ajani","year":"2015","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejphar.2020.173840_bib2","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","article-title":"Perturbations of the AKT signaling pathway in human cancer","volume":"24","author":"Altomare","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2020.173840_bib3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s41388-018-0510-y","article-title":"Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas","volume":"38","author":"Arima","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2020.173840_bib4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nrc1740","article-title":"Opinion: the origin of the cancer stem cell: current controversies and new insights","volume":"5","author":"Bjerkvig","year":"2005","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejphar.2020.173840_bib5","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3892\/ijo.2014.2325","article-title":"Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt\/NF-kappaB\/mTOR signaling proteins and anti-apoptotic Bcl-2","volume":"44","author":"Deeb","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2020.173840_bib6","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.3892\/ijo.2014.2350","article-title":"A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors","volume":"44","author":"Ding","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2020.173840_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/antiox6030052","article-title":"Silencing of NRF2 reduces the expression of ALDH1A1 and ALDH3A1 and sensitizes to 5-FU in pancreatic cancer cells","volume":"6","author":"Duong","year":"2017","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2020.173840_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.canlet.2013.06.020","article-title":"Overview: cellular plasticity, cancer stem cells and metastasis","volume":"341","author":"Elshamy","year":"2013","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejphar.2020.173840_bib9","doi-asserted-by":"crossref","first-page":"3J","DOI":"10.1016\/S0002-9149(98)00423-8","article-title":"Current and future treatment of hyperlipidemia: the role of statins","volume":"82","author":"Farnier","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2020.173840_bib10","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejphar.2020.173840_bib11","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.ejca.2005.04.044","article-title":"Molecular prognostic markers in pancreatic cancer: a systematic review","volume":"41","author":"Garcea","year":"2005","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.ejphar.2020.173840_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.canlet.2018.09.028","article-title":"Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity","volume":"439","author":"Gupta","year":"2018","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejphar.2020.173840_bib13","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0140-6736(05)75962-6","article-title":"COX-2 inhibitors","volume":"353","author":"Hawkey","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2020.173840_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","article-title":"Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer","volume":"1","author":"Hermann","year":"2007","journal-title":"Cell. Stem. Cell."},{"key":"10.1016\/j.ejphar.2020.173840_bib15","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/ijc.24573","article-title":"CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells","volume":"125","author":"Hong","year":"2009","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejphar.2020.173840_bib16","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41401-019-0317-6","article-title":"Adipose-derived mesenchymal stem cells protect against CMS-induced depression-like behaviors in mice via regulating the Nrf2\/HO-1 and TLR4\/NF-kappaB signaling pathways","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2020.173840_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MPA.0b013e3181c0decc","article-title":"Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of interferon-stimulated gene 15 kDa is associated with intrinsic chemoresistance","volume":"39","author":"Ina","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.ejphar.2020.173840_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1158\/1541-7786.MCR-08-0393","article-title":"Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer","volume":"7","author":"Jiang","year":"2009","journal-title":"Mol. Canc. Res."},{"key":"10.1016\/j.ejphar.2020.173840_bib19","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1182\/blood-2008-08-172726","article-title":"Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide","volume":"113","author":"Karp","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2020.173840_bib20","first-page":"2925869","article-title":"Targeting signaling pathways in cancer stem cells for cancer treatment","volume":"2017","author":"Koury","year":"2017","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.ejphar.2020.173840_bib21","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification of pancreatic cancer stem cells","volume":"67","author":"Li","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejphar.2020.173840_bib22","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1038\/srep03230","article-title":"mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions","volume":"3","author":"Matsubara","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173840_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107142","article-title":"ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling","volume":"9","author":"Meng","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173840_bib24","doi-asserted-by":"crossref","first-page":"6978","DOI":"10.1158\/0008-5472.CAN-04-1150","article-title":"Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase2A B56gamma knockdown","volume":"64","author":"Moreno","year":"2004","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejphar.2020.173840_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.seminoncol.2007.05.009","article-title":"Cytotoxic therapy for advanced pancreatic adenocarcinoma","volume":"34","author":"O'Reilly","year":"2007","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejphar.2020.173840_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrm1004","article-title":"CD44: from adhesion molecules to signalling regulators","volume":"4","author":"Ponta","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2020.173840_bib27","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/stem.2114","article-title":"Concise review: stem cells in pancreatic cancer: from concept to translation","volume":"33","author":"Raj","year":"2015","journal-title":"Stem Cell."},{"key":"10.1016\/j.ejphar.2020.173840_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173840_bib29","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA. Cancer. J. Clin."},{"key":"10.1016\/j.ejphar.2020.173840_bib30","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA. Cancer. J. Clin."},{"key":"10.1016\/j.ejphar.2020.173840_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrclinonc.2009.236","article-title":"Advanced pancreatic carcinoma: current treatment and future challenges","volume":"7","author":"Stathis","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2020.173840_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/156800908783497140","article-title":"Deregulation of the Akt pathway in human cancer","volume":"8","author":"Tokunaga","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejphar.2020.173840_bib33","doi-asserted-by":"crossref","first-page":"11018","DOI":"10.18632\/oncotarget.6920","article-title":"Aldehyde dehydrogenase 1A1 in stem cells and cancer","volume":"7","author":"Tomita","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2020.173840_bib34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2217\/nnm.12.22","article-title":"Cancer stem cells and drug resistance: the potential of nanomedicine","volume":"7","author":"Vinogradov","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejphar.2020.173840_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrgastro.2010.188","article-title":"Pancreatic cancer: understanding and overcoming chemoresistance","volume":"8","author":"Wang","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173840_bib36","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/gb-2008-9-3-r53","article-title":"Systems biology-defined NF-kappaB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status","volume":"9","author":"Yan","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejphar.2020.173840_bib37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.canlet.2018.11.007","article-title":"HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival","volume":"442","author":"Yan","year":"2019","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejphar.2020.173840_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12943-015-0449-3","article-title":"Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine","volume":"14","author":"Yang","year":"2015","journal-title":"Mol. Canc."},{"key":"10.1016\/j.ejphar.2020.173840_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cas.12817","article-title":"Therapeutic strategies targeting cancer stem cells","volume":"107","author":"Yoshida","year":"2016","journal-title":"Canc. Sci."},{"key":"10.1016\/j.ejphar.2020.173840_bib40","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/jcb.26346","article-title":"The inhibitory effect of 5,7-DMF on pancreatic sphere-forming cell function mediated by FoxM1 gene expression","volume":"119","author":"Zeng","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2020.173840_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12514","article-title":"Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1","volume":"52","author":"Zhou","year":"2019","journal-title":"Cell Prolif"},{"key":"10.1016\/j.ejphar.2020.173840_bib42","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.pan.2018.02.006","article-title":"Celecoxib suppresses proliferation and metastasis of pancreatic cancer cells by down-regulating STAT3\/NF-kB and L1CAM activities","volume":"18","author":"Zuo","year":"2018","journal-title":"Pancreatology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920309456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920309456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:11:23Z","timestamp":1762143083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920309456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":42,"alternative-id":["S0014299920309456"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173840","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cancer sphere-forming cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173840"}}